Skip links

Ztalmy® (ganaxolone)

Full Name Ztalmy® (ganaxolone)
Drug Ztalmy
Manufacturer Marinus Pharmaceuticals
Route of Administration Oral
Site of Care Home
Approved Indication The treatment of seizures associated with cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD) in patients 2 years of age and older
Disease Cyclin-dependent kinase-like 5 (CDKL5) Deficiency Disorder
Therapeutic Area Neurology
Referral Link Ztalmy Enrollment Form
Phone Number 844-ZTALMY1
Fax Number 844-ZTALMYF